Fabio Antonaci
Torbjørn Fredriksen
Juan A. Pareja3
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
- 1Department of Brain and Behavioral Sciences, C. Mondino National Institute of Neurology Foundation, IRCCS, University of Pavia, Pavia, Italy
- 2Department of Neurosurgery, St. Olavs Hospital, Trondheim University Hospitals, Trondheim, Norway
- 3Department of Neurology, University Hospital Fundación Alcorcón, Madrid, Spain
- 4Department of Neurology, St. Olavs Hospital, Trondheim University Hospitals, Norwegian University of Science and Technology, Trondheim, Norway
A corrigendum on
Shortlasting, Unilateral, Neuralgiform, Headache Attacks With Conjunctival Injection, Tearing, Sweating and Rhinorrhea: The Term and New View Points
by Antonaci, F., Fredriksen, T., Pareja, J. A., and Sjaastad, O. (2018). Front. Neurol. 9:262. doi: 10.3389/fneur.2018.00262
The title of the original article was changed from Shortlasting Unilateral Neuralgiform Conjunctival Injection and Tearing Syndrome: The Term and New View Points to Shortlasting, Unilateral, Neuralgiform, Headache Attacks With Conjunctival Injection, Tearing, Sweating and Rhinorrhea: The Term and New View Points.
In addition, a correction has been made to the last sentence of the section The IHS Criteria and should read:
“Duration has been given as [4]: 5–240 s (and for SUNA: 2 s – 10 min).”
The corrected paragraph appears below:
The IHS Criteria
Then, the IHS 2004 version (4) and later the 2013 version (5) of the headache classification provided instructions that made conjunctival injection and tearing obligatory phenomena, in SUNCT. To introduce a “must” in this connection is, as we see it, a misunderstanding. That conjunctival injection and tearing are included in the acronym does not imply that these are the only autonomic variables, in SUNCT, and that their presence is absolute. Beside “sweating and rhinorrhoea,” legion autonomic disturbances can be incorporated. Thus, in the early review [7], there were around 10 more autonomic variables, and one or more of them that might be valid. There is considerable uncertainty concerning duration of attacks. Duration has been given as [4]: 5–240 s (and for SUNA: 2 s-10min).
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way.
The original article has been updated.
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Keywords: shortlasting unilateral neuralgiform conjunctival injection and tearing, short-lasting unilateral neuralgiform headache attacks with cranial autonomic symptoms, trigeminal neuralgia, autonomic nervous system dysfunction, unilateral headaches
Citation: Antonaci F, Fredriksen T, Pareja JA and Sjaastad O (2018) Corrigendum: Shortlasting, Unilateral, Neuralgiform, Headache Attacks With Conjunctival Injection, Tearing, Sweating and Rhinorrhea: The Term and New View Points. Front. Neurol. 9:547. doi: 10.3389/fneur.2018.00547
Received: 15 May 2018; Accepted: 19 June 2018;
Published: 18 July 2018.
Edited and reviewed by: Massimiliano Valeriani, Bambino Gesù Ospedale Pediatrico (IRCCS), Italy
Copyright © 2018 Antonaci, Fredriksen, Pareja and Sjaastad. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Fabio Antonaci, ZmFiaW8uYW50b25hY2lAdW5pcHYuaXQ=